Novel therapeutic approaches in cardiovascular diseases may thus also target adipose tissue since the adipose-derived CTRP9 as well as adiponectin have been shown to mediate strong anti-inflammatory and anti-oxidative vascular effects [50,52,53]. This evidence concerns the gene C1QTNF9 and cardiovascular disorder.